MedTrace Logo

Protocol: Balance Training in Parkinson's Disease

NCT02488265 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2018-11-02

No results posted yet for this study

Summary

Postural instability is a particularly incapacitating disorder, where loss of motor independence by Parkinson´s Disease (PD) patients marks a significant stage of disease onset. Evidence suggests that deficits in automatic motor control, sensory integration and attention are associated with lack of balance in PD. Physiotherapy, together with medication, plays an important role in the treatment of this state, although no consensus has been reached on the best treatment modality. The aim of this randomized controlled trial protocol is to evaluate the effects of balance training with rhythmical (BRT), which is a motor program to improve balance associated with rhythmical auditory cues (RACs)

Conditions

  • Parkinson Disease

Interventions

OTHER

Balance Training

Balance training with rhythmical (BRT), is a motor program to improve balance associated with rhythmical auditory cues (RACs).

OTHER

Screening to prevent falls

Questionary to Scheduled screening falls and progression in training will be used to indicate the capacity to continue to progress.

Sponsors & Collaborators

  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • Maria Elisa P Piemonte, PhD · University of Sao Paulo

  • Tamine TC Capato, Master · University of Sao Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-01
Primary Completion
2017-05-30
Completion
2017-12-20

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02488265 on ClinicalTrials.gov